APA
Robinson G. W., Rudneva V. A., Buchhalter I., Billups C. A., Waszak S. M., Smith K. S., Bowers D. C., Bendel A., Fisher P. G., Partap S., Crawford J. R., Hassall T., Indelicato D. J., Boop F., Klimo P., Sabin N. D., Patay Z., Merchant T. E., Stewart C. F., Orr B. A., Korbel J. O., Jones D. T. W., Sharma T., Lichter P., Kool M., Korshunov A., Pfister S. M., Gilbertson R. J., Sanders R. P., Onar-Thomas A., Ellison D. W., Gajjar A. & Northcott P. A. (20190409). Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. : The Lancet. Oncology.
Chicago
Robinson Giles W, Rudneva Vasilisa A, Buchhalter Ivo, Billups Catherine A, Waszak Sebastian M, Smith Kyle S, Bowers Daniel C, Bendel Anne, Fisher Paul G, Partap Sonia, Crawford John R, Hassall Tim, Indelicato Daniel J, Boop Frederick, Klimo Paul, Sabin Noah D, Patay Zoltan, Merchant Thomas E, Stewart Clinton F, Orr Brent A, Korbel Jan O, Jones David T W, Sharma Tanvi, Lichter Peter, Kool Marcel, Korshunov Andrey, Pfister Stefan M, Gilbertson Richard J, Sanders Robert P, Onar-Thomas Arzu, Ellison David W, Gajjar Amar and Northcott Paul A. 20190409. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. : The Lancet. Oncology.
Harvard
Robinson G. W., Rudneva V. A., Buchhalter I., Billups C. A., Waszak S. M., Smith K. S., Bowers D. C., Bendel A., Fisher P. G., Partap S., Crawford J. R., Hassall T., Indelicato D. J., Boop F., Klimo P., Sabin N. D., Patay Z., Merchant T. E., Stewart C. F., Orr B. A., Korbel J. O., Jones D. T. W., Sharma T., Lichter P., Kool M., Korshunov A., Pfister S. M., Gilbertson R. J., Sanders R. P., Onar-Thomas A., Ellison D. W., Gajjar A. and Northcott P. A. (20190409). Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. : The Lancet. Oncology.
MLA
Robinson Giles W, Rudneva Vasilisa A, Buchhalter Ivo, Billups Catherine A, Waszak Sebastian M, Smith Kyle S, Bowers Daniel C, Bendel Anne, Fisher Paul G, Partap Sonia, Crawford John R, Hassall Tim, Indelicato Daniel J, Boop Frederick, Klimo Paul, Sabin Noah D, Patay Zoltan, Merchant Thomas E, Stewart Clinton F, Orr Brent A, Korbel Jan O, Jones David T W, Sharma Tanvi, Lichter Peter, Kool Marcel, Korshunov Andrey, Pfister Stefan M, Gilbertson Richard J, Sanders Robert P, Onar-Thomas Arzu, Ellison David W, Gajjar Amar and Northcott Paul A. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. : The Lancet. Oncology. 20190409.